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Summary: We describe the development of radioimmunoassays to measure both human pepsinogen A and
pepsinogen C concentrations in serum. The antibodies were raised in goats by immunization with purified
pepsinogen A or C. The affinity constants of the respective antibodies were 20 · l O101/mol and 7 · l O101/mol.
Pepsinogens A and C were labeled with Na 125I by the chloramine T method. The binding between labels and
antibodies was inhibited by 0.50 at 0.82 ng pepsinogen A per tube and 2.1 ng pepsinogen C per tube. The
detection limits of the assay of pepsinogen A and C were 0.12 μg/l and 1.8 μg/l, respectively.
Pepsinogen A and C were purified and added to a patient serum, showing a good recovery in the radioim-
munoassays. Serial dilution of another patient serum, which contained a high concentration of both antigens,
showed curves parallel to the Standard curves. The intra- and interassay variations of these radioimmunoassays
were evaluated. The intra-assay coefficients of Variation for pepsinogen A were found to vary from 0.03 to
0.102 at concentrations in serum in the normal r nge, while the inter-assay coefficient of Variation ranged
from 0.118 to 0.194 at the same concentrations in serum. For the pepsinogen C radioimmunoassay we found
intra-assay coefficients of Variation between 0.126 and 0.147 at concentrations in serum in the normal r nge,
while the inter-assay coefficient of Variation ranged from 0.174 to 0.325 for the same sera.
In 201 blood donors we found a me n serum concentration of pepsinogen A of 59 μg/l and a mean serum
concentration of pepsinogen C of 15 μg/l. There was a significant relationship between these values (r = 0.779,
p < 0.001).
The concentrations of both pepsinogens were increased in 10 patients with duodenal ulcer (132 and 67 μg/l,
respectively). Serum pepsinogen A was decreased in 14 patient« with partial gastrectomy (34 μg/l) and in 6
with achlorhydria (9 μg/l), accompanied by raised (34 μg/l) and!inormal (20 μg/l) mean pepsinogen C concen-
trations in the respective groups. In 4 patients with a total gastrectomy the mean serum concentration of
both pepsinogen A and C reached the zero level (5 and 4 μg/l, respectively). These results not only underline
the accuracy of the measurements but also point to their clinical relevance.
ntro uction .§ secrete^ by fun(jjc, pyloric and proximal duodenal
Pepsinogen A and C are the proenzymes of pepsin A mucosa (1). Exocrine-secreted pepsinogens function
and pepsin C, respectively, which belong to the group s zymogens for the main proteolytic activity of gas-
of gastric acid aspartic endoproteiiiases. Pepsinogen tric juice. There is also a small endocrine excretion of
A is secreted by fundic mucosa, while pepsinogen C pepsinogens without a known function, but by ex-
ploiting this phenomenon, we can gain Information
~ on the condition of the gastric mucosa by measure-
Pepsin* *Α; EC 3 4.23.1 ment of the serum concentration of pepsinogen A and
Pepsin C; gastricsin; EC 3.4.23.3 pepsinogen C (2, 3).
J. Clin. Chem. Clin. Biochem. / Vol. 27,1989 / No. l
20 Biemond et al.: Radioimmunoassay of pepsinogens
As the concentration of both zymogens in serum is
low, we developed a radioimmunoassay to measure
pepsinogen A and C in serum. This report describes
a protocol for the Isolation of pepsinogen A and C
from gastric mucosa, the production of antibodies
against these antigens in goats, the conditions of the
radioimmunoassay, and the distribution of serum pep-
sinogen A and C in blood transfusion donors and in
patients with duodenal ulcer, atrophic gastritis, and
partial or total gastrectomy.
Materials and Methods
Reagents
Na 125I was purchased from New England Nuclear, Boston,
MA, USA; diethylaminoethyl(DEAE)-Cellulose DE-52 from
Whatman, Maidstone, England, UK; Sephadex® G100, PD-
10® colurans, Mono Q® (high pressure resistant monodisperse
anion exchanger), and decanting Suspension 2 (Micro-Sephar-
ose® beads coupled with horse anti-sheep/goat immunoglobulin
antibodies) from Pharmacia, Uppsala, Sweden; cellulose di-
alysis membrane, disodium ethylene-diaminetetraacetic acid
(EDTA), bis[2-hydroxyethyl]imino-tris-[hydroxymethyl]-meth-
ane(BIS-TRIS), and bovine haemoglobin from Sigma, St.
Louis, MO, USA; all other reagents from E. Merck, Darmstadt,
F. R. G. Nonimmune horse serum was obtained from a local
abattoir.
Equipment
Radioactivity was measured by an automatic gamma-scintilla-
tion counter, the Clinigamma 1272, with four 1.5 inch NaI
crystals from Wallac Oy, Turku, Finland. High pressure anion
exchange chromatography was performed with the FPLC®
System from Pharmacia, Uppsala, Sweden.
Gastric mucosa
The stomach of a patient with a Zollinger-Ellison syndrome
was cut open along the minor curvature. The mucosa from the
corpus was stripped off the muscle layer, divided in parts and
frozen.
Isolation of pepsinogen A and pepsinogen C
After thawing, the mucosa was homogenized in 0.02 mol/1
Phosphate buffer, pH 7.5 (3 ml/g of tissue) with a Sorvall®
Omnimixer at maximum speed for 3 minutes on ice. The ho-
mogenate was centrifuged at 36500# at 4°C for 15 minutes.
The supernatant was decanted and once more centrifuged at
100000g at 4°C for 60 minutes. After decanting, the super-
natant was dialysed overnight against the same buffer.
The retentate was applied to the top of a column (2.6 χ 40
cm) packed with DEAE-Cellulose to a bed height of 17 cm and
equilibrated with the above described phosphate buffer. The
column was washed with 125 ml 0.1 mol/1 NaCl in the equili-
bration buffer. The pepsinogens were eluted in a single peak
by a linear gradient of 200 ml ranging from 0.10 mol/1 to 0.48
mol/1 NaCl in the equilibration buffer. The eluate fractions
containing most proteolytic activity were pooled and dialysed
against phosphate buffer.
The pooled pepsinogens were further purified by gel permeation
chromatography on a 2.6 χ 100 cm column with a flow adaptor
packed with Sephadex® G 100 to a bed height of 93 cm in
phosphate buffer at 4 °C.
All material from the Sephadex G100 absorbing at 280 nm,
was adsorbed to Mono Q® anion exchanger, then separated
into pepsinogen C and pepsinogen A by FPLC® (fig. 1). The
peaks of pepsinogen A were pooled and apart from the pepsi-
nogen C peak thoroughly dialysed against distilled water and
lyophilized.
Analyt ical methods
Proteolytic activity was monitored in column ehiate fractions
by incubating 0.1 ml of an appropriate dihition of sample with
2.5 ml bovine haemoglobin solution (2.5 g/l bovine haemoglo-
bin in 0.06 mol/i HC1) at 37 °C for 10 min. The reaction was
stopped with 5.0 ml of 0.31 mol/1 trichioroacetic acid. The
digest was filtered, and the absorbance of the flltrate was
determined at 280 nm.
FPLC® was performed according to Defize et aL (4). Pepsino-
gens in phosphate buffer were applied to a 0.5 χ 5 cm column,
packed with Mono Q®, and equilibrated in 0.025 mol/1 BIS-
TRIS/hydrochloric acid, pH 6.0. The column was washed with
4ml 0.12 mol/1 NaCl in equilibration buffer, and the pepsino-
gens were eluted with 21 ml of a linear gradient of NaCl iri
equilibration buffer, ranging from 0.12 to 0.4 mol/1. Fractions
of 0.5 ml were collected. Absorbance at 280 nm was continu-
ously measured in the eluate.
Antibody production
Antibodies to pepsinogen A and pepsinogen C were raised in
two different goats. Primary immunizatipn was done by sub-
cutaneous injection of an emulsion of l ml Freunds complete
adj vant and l ml solution of antigen in saline (l g/l). The
animals were bopsted by monthly injections of an emulsion of
l ml Freunds incomplete adj vant and l ml solution of antigen
in saline (0.5 g/l), and bled at two week intervals. The injection
scheme was continued for more than two years.
Dilution curves of goat anti-pepsinogen A for 4 different bleed-
ing times were compared and the best selected. A goat anti-
pepsinogen C antiserum, taken at a randomly chosen bleeding
time, showed an appropriate dilution curve.
Radioiodination
Pepsinogens A and C were labeled with Na 125I by the chlora-
mine T method (5). The incubation mixture contained 5μg
pepsinogen A or pepsinogen C in 5 μΐ 0.05 raol/1 phosphate
buffer, pH 7.5, 20 μΐ 0.5 mol/1 phosphate buffer, pH 7.5, 5 μΐ
Na 125I solution (3700 GBq/1) and 10 μg (10 μΐ) chloramine T.
The mixture was incubated for 30 s at 0 °C. The reaction was
stopped by addition of 20 μg (10 μΐ) sodium metabisulphite
and diluted with 1.0 ml 0.05 mol/1 phosphate buffer, pH 7.5.
Labeled pepsinogens and inorganic 12SI were separated on a
PD-10® column (15.2 χ 50 mm) which was equilibrated and
eluted with 0.05 mol/1 phosphate buffer, pH 7.5. Ehiate frac-
tions of 1.0 ml were collected into tubes containing 10 μΐ horse
serum. The fraction next to the void volurne fraction was used
and diluted in 0.01 mol/1 phosphate-buffered saune containing
10 ml/l horse serum.
Radioimmunoassay s
Pepsinogen A and pepsinogen C were bolh measured by a
competitive binding assay in which bound and free antigen
were separated by Micro-Sepharose® beads coupled to horse
anti sheep/goat immunoglobulin antibodies. The diluent buffer
was a mixture of 6 volumes 0.01 mol/1 phosphate buffered
saline, pH 7.5, and one volume 0.1 mol/1 EDTA in water,
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supplemented with 10 ml/l nonimmune horse serum. Diluent
buffer, antiserum diiution, Standards or test sera were added to
11.5 χ 55 mm disposable polystyrene tubes to a final volume
of l ml.
For the radioimmunoassay of pepsinogen A the incubation
mixture contained 400 μΐ diluent buffer, 200 μΐ pepsinogen A
Standard or 10-fold dilutcd test serum, 200 μΐ goat anti-pepsi-
nogen A in a final diiution of l: 300 000, and 200 μΐ I25l-iabelled
pepsinogen A in diluent buffer to provide about 4000 counts/
min (120 Bq per tube).
For the radioimmunoassay of pepsinogen C the same scheme
was applied but 125I-labelled pepsinogen C was used s label,
goat anti-pepsinogen C was used in a final diiution of
l : 200 000, and the test sera were used in a 5-fold diiution in
buffer.
After incubation for 96 h at 4 °C, 200 μΐ decanting Suspension
containing Micro-Sepharose® beads coupled with horse anti-
sheep/goat immunoglobulin antibodies was dispensed, stirred,
and incubated at room temperature for 2 hours. The tubes were
then centrifuged at 4500g for 10 min, the supernatant was
decanted and the radioactivity of the pellet was counted for
5 min in a automatic gamma counter.
Standards were prepared by dissolving a weighed quantity of
lyophilized pepsinogen A or C in diluent buffer. All Standards
and test sera were set up in duplicatc. The bound radioactivity
was corrected for nonspecific binding by subtracting the raean
radioactivity in the nonspecific binding tubes from that in the
Standards and unknowns. Standard curves were calculated by
linear regression of the logit transfonned B/B0 ratio with the
logarithm of the Standard concentration. The affinities of the
antisera were calculated according to Scatchard (6).
Five control sera were used for measurement of the intra- and
inter-assay Variation, containing 3, 27, 39, 81, and 317 μg/l
pepsinogen A and 10, 22, 8, 12, and 523 μg/l pepsinogen C,
respectively.
Test sera
Serum was obtained from 201 different blood transfusion do-
nors, 130 males and 71 females, ranging in age between 18 and
64 years; from 10 patients with duodenal ulcer (8(?, 2?; age
21—63 years); from 14 patients who had undergone a partial
gastrectomy (12(J, 2$; age 27-71 years) of which 7 had a
gastroduodenostomy and the others a gastrojejunostomy; from
4 patients with a total gastrectpmy (3 <y, l ?; age 63-84 years);
and from 6 patients with achlorhydria due to atrophic gastritis
(4 c?, 2 ?; age 53-78 years).
Statistical analysis
Studenfs t test using a popled or separate variance estimate,
dependmg on the homogeneity of both variance, was applied
to evaluate the significance of differences between the means
of two groups. The significance of differences between the
means of more than two groups was evaluated by the ratio of
variances within and between gr ups. The level of significance
was taken at 0.05.
Results
Purification and characterization
FPLC® anion exchange chromatography of the par-
tially purified pepsinogens on Mono Q® produced 4
major peafcs of absorbance at 280 nm, all of which
showed proteolytic activity (fig. 1). The ratio between
0.2
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Fig. 1. FPLC^-gel permeation chromatography of gastric acid
proteases on Mono Q® anion exchanger, using a chlo-
ride gradient. Solid line: absorbance at 280 nm; dashed-
dotted line: absorbance increment at 280 nm per min
during incubation of filtrate from bovine haemoglobin
incubated with eluted fraction; dashed line: Chloride
gradient. The first peak eluted at 10 ml represents pep-
sinogen C, while the following 3 peaks represent iso-
zymogens of pepsinogen A.
proteolytic activities was 2.2 for the first peak and
0.8 for the 3 following peaks. The first peak, further
referred to s pepsinogen C, was immunologically
distinguishable from the pooled 3 other peaks, further
referred to s pepsinogen A; differentiation was pos-
sible with the aid of goat anti-pepsinogen C, which
did not bind to radiolabeled pepsinogen A, and goat
anti-pepsinogen A, which did not react with radioiod-
inated pepsinogen C. Furthermore, pepsinogen C
showed no Inhibition of the binding of goat anti-
pepsinogen A and labeled pepsinogen A, and pepsi-
nogen A showed no Inhibition of the binding between
goat anti-pepsinogen C and radiolabeled pepsinogen
C (fig. 2).
100 1000
Pepsinogen concentration
10 100 1000
Fig. 2. Left: Ratio of bound fraction to total radioactivity
versus decadic logarithm of concentration using radio-
labeled pepsinogen A and goat anti-pepsinogen A. Pep-
sinogen A (o) binds to antibody, but not to pepsinogen
C(x).
Right: Ratio of bound fraction to total radioactivity
versus decadic logarithm of concentration using radio-
labeled pepsinogen C and goat anti-pepsinogen C. Pep-
sinogen C (o) binds to antibody, but not to pepsinogen
A(x).
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Radio immunoassay of pepsinogen A
Radiolabeled pepsinogen A was found lo have a spe-
cific activity of 0.318 MBq^g. Thus each tube con-
tained about 0.5 ng radiolabeled pepsinogen A. About
0.45 of radioactivity was bound by goat anli-pepsi-
nogen A serum in a final dilution of l: 300 000. The
nonspecific binding was about 0.01 —0.02. The equi-
librium constant was found to be 20 · l O101/mol under
the conditions of the assay. The detection limit, cor-
responding to two Standard deviations less than the
mean counts bound in 5 zero Standards in duplicate,
was 0.12 μg/l. The 0.50 inhibitory dose was about
0.82 ng/tube. This high sensitivity allowed us to use
the test sera in a 10-fold dilution.
A calibration curve in which the concentration of
pepsinogen A Standard ranged from 0.44 to 112 μg/l
(0.09 to 22.5 ng/tube) is shown in figure 2. Pepsinogen
C to a concentration of 340 μg/l did not compete in
the assay (fig. 2), and goat anti-pepsinogen C in a
final dilution of l : 200 000, did not bind radiolabeled
pepsinogen A. ,
The recovery of pepsinogen A from a serum spiked
with pepsinogen A Standard in concentrations ranging
from 0.44 to 112 μg/l varied between 0.813 and 1.297
with a median of 1.032 (fig. 3). A control serum
containing a high concentration of pepsinogen A and
C was serially 2-fold diluted up to l : 512 and showed
a curve parallel to the Standard curve (fig. 3). The
intra-assay coefficients of Variation for pepsinogen A
were found to vary from 0.030 to 0.102 at concentra-
tions in serum in the normal r nge, while the inter-
assay coefficient of Variation, determined over a one-
month period, ranged from 0.118 to 0.194 at the same
serum concentrations (fig. 4).
Radioimmunoassay of pepsinogen C
Radiolabeled pepsinogen C had a specific activity of
0.651 MBq^g. Thus each tube contained about 0.18
ng radioiodinated pepsinogen C. About 0.55 of ra-
dioactivity was bound by goat anti-pepsinogen C
serum in a final dilution of l: 200 000. The nonspecific
binding was about 0.01^0.02. The .equilibrium con-
stant was found to be 7 · 10·° 1/mol under the condi-
tions of the assay. The detection limit, coirrespoiiding
to two Standard deviations less than the mean counts
bound in 5 zero Standards in duplicate, was 1.8 μg/l.
The 0.50 inhibitory dose was about 2.1 ng/tube. This
sensitivity allowed us to use the test sera in a 5-fold
dilution.
A calibration curve in which the concentration of
pepsinogen C Standard ranged from 0.66 to 169 μ£/1
(0.13 to 34 ng per tube) is shown in figure 2. Pepsi-
nogen A to a concentration of 225 μg/l did not com-
pete in the assay (fig. 2), and goat anti-pepsinogen A
in a final dilution of 1:300000 did not bind r dio-
labeled pepsinogen C.
The recovery of pepsinogen C from serum spiked with
pepsinogen C Standard in concentrations ranging
from 2.64 to 169 μg/l varied between 0.859 and 1.395
with a median of 1.159 (fig. 2). A control serum
containing a high concentration of pepsinogen A and
C was serially 2-fold diluted up to l: 128 and showed
a curve parallel to the Standard curve (fig. 3). For the
pepsinogen C radioimmunoassay we found an intra-
assay coefficient of Variation between 0.126 and 0.147
at serum levels in the normal r nge, while the inter- .
assay coefficient of Variation, determined over a one-
month period, ranged from 0.174 to 0.325 for the
same sera (fig. 4).
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Fig. 3. Standard curve (+) of logit transfonned B/B0 versus
decadic logarithm of concentration using radiolabeled
pepsinogen A (left) or pepsinogen C (right) and goat
anti-pepsinogen A (left) or goat anti-pepsinogen C(right).
Recovery (o) of lyophilized pepsinogen A (left) or pep-
sinogen C (right) added to a human serum.
Dilution curve (x) of patient serum containing a high
concentration of both pepsinogen A and C.
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Fig. 4. Intra-assay (β-β) and interassay (χ-χ) Variation ex-
pressed s Standard deviation (SD) or%'coefficient of
Variation (CV) of pepsinogen A (left) and pepsinogen
C (right) in 6 duplicate determinations.
SDCV is given s the quotient CV = -^ -.
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Tab. 1. Means (x) and Standard deviations (SD) of the concentrations of serum pepsinogens A and C (pg/l) and the ratio of
pepsinogen A and pepsinogen C in blood transfusion donors and different patient groups.
Blood transfusion donors
— males
— females
Duodenal ulcer disease
Partial gastrectomy
— gastroduodenostomy
— gastrqjejunostomy
Total gastrectomy
Atrophie gastritis
n
201
. 130
71
10
14
7
7
4
6
Pepsinogen
X
59
65'
48
132*
34*
28*
41
5*
9*
A
SD
28
29
22
57
29
15
39
4
8
Pepsinogen
X
15
16
13
67*
34*
26*
42
4*
20
C
SD
12
12
11
25
31
18
40
4
17
Ratio
X
5.2
5.1
5.4
2.1*
4.4
4.7
2.5*
0.5*
0.8*
SD
3.1
2.4
4.1
0.8
7.4
9.4
4.2
0.5
0.7
t significant different between males and females
* significant different from blood donors
Pepsinogen A and C concentrations in test
sera
The mean serum concentration (± SD) of pepsinogen
A in blood transfusion donors was 59 (±28) μg/l
(tab. 1). The serum concentration of pepsinogen A
showed a leptokurtic and positively skewed distribu-
tion, which could be nearly normalized by square-
root transformation. In males the mean concentration
of pepsinogen A in serum was 65 (± 29) μg/l and in
females a mean concentration of 48 (± 22) μ§/1 was
found; this difference was statistically significant
(tab. 1).
Pepsinogen C was found to be 15 (± 12) μg/l for all
blood transfusion donors (tab. 1). The serum concen-
tration of pepsinogen C showed a leptokurtic and
positively skewed distribution, which could be partly
normalized by square-root transformation. In con-
trast to pepsinogen A (tab. 1), the mean concentration
in males (16 ± 12 μg/l) was not statistically different
from that in females (13 ± 11 μg/l).
Serum pepsinogen A, C and its ratio in relation to
the age of the blood transfusion donors showed a
gradual increase of both pepsinogen A and C with
increasing age of the donors. The ratio tended to
decrease in older people (tab. 2).
Patients with duodenal ulcer showed an increase of
serum pepsinogens A and C, while the ratio decreased,
due to the relatively strong increase of pepsinogen C.
Patients having undergone partial gastrectomy s well
s patients with achlorhydria showed decreased levels
of pepsinogen A, but equal or even increased levels
of pepsinogen C. The ratio also tended to decrease,
and atrophic gastritis patients had an especially low
ratio. Total gastrectomy caused a strong decrease in
the serum concentrations of both pepsinogens and
their ratio (tab. 1).
In figure 5 the pepsinogen A concentration in serum
was plotted against pepsinogen C in both patients
and blood donors. There was a highly significant
overall correlation between both concentrations
(r = 0.671, p < 0.001). For blood donors and differ-
ent_groups of patients the correlation was found to
be equally strong, except for patients with duodenal
ulcer, for which the correlation coefficient was found
to be much lower. The blood donors and each group
of patients are characterized by their own intercept
and slope of the regression line.
Tab. 2. Means and Standard deviations of the concentrations of serum pepsinogens A and C fag/I) and the ratio of pepsinogen
A and pepsinogen C in different £ge groups of blood transfusion donors.
Age group (a)
20-29
30-39
40-49
50^59
60-64
n
60
60
53
21
6
Pepsinogen A*
χ SD
50 20
61 29
63 27
73 34
69 37
Pepsinogen C*
χ SD
12 7
15 13
17 11
19 16
23 6
Ratio
X
5.6
5.1
5.0
5.2
3.0
SD
4.1
2.2
3.1
2.4
1.4
significant ratio of within and between variances
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250 r
40 60
Pepsinogen C
Fig. 5. Relationship between serura pepsinogen A and serum
pepsinogen C in blood donors and different groups of
patients. Solid line: regression line (r = 0.779;
y = 1.88x + 30.87) in blood donors (o). Dashed line:
regression line (r = 0.473; y = l .09 -h 60.23) in pa-
tients with duodenal ulcer (o). Dotted line: regression
line (r = 0.790; y = 0.75 + 9.10) in patients having
undergone partial gastrectomy (+). Dotted-dashed line:
regression line (r = 0.706; y = 0.33 + 2.76) in patients
with atrophic gastritis ( ). Patients with total gastrec-
tomy ( ).
Discussion
We describe the purification and radioimmunoassays
of pepsinogens A and C and their serum concentration
distribution in blood transfusion donors, in patients
suffering from duodenal ulcer disease, in those having
undergone partial or total gastrectomy, and in pa-
tients with achlorhydria.
With the purification of pepsinogens we followed
partially the procedure described by Samloff (7).
However for the Separation of pepsinogen A from
pepsinogen C we used anion exchange chromatogra-
phy on Mono Q® by FPLC®. With a Chloride gra-
dient, pepsinogen C can be predicted to elute first
from Mono Q®, in agreement with the order of elution
of pepsinogens from Mono Q®- and DEAE anion
exchangers by a chloride gradient äs described by
other authors (4, 7, 9). It has been shown in other
studies (7, 10) that pepsinogen A is immunologically
distinct from pepsinogen C; since the first peak ap-
peared to be immunologically distinct from the fol-
lowing 3 peaks of the elution profile, we assigned the
first peak in figure l to pepsinogen C and the others
to pepsinogen A. The isozymogen profile of pepsi-
nogen A from this study differs from that published
before by Defize et al. (4), äs these authors showed
pepsinogen A to have 4 isozymogens. The reason for
this discrepancy is probably genetically determined.
It is known that the isozymogen profile of pepsinogen
A is under genetic control (8), and the number of
isozymogens of pepsinogen A and their intensity
ies individually.
From figure l it is evident that the ratio between
proteolytic activity and absorbance is larger for the
pepsinogen C than for the pepsinogen A peaks. This
finding has also been reported previously by Samloff
(7).
In this study, the Standards with the highest immu-
noreactivity were selected. For pepsinogen C in blood
donors we found a mean value comparable to that of
the controls published by Samloff (7); however, for
pepsinogen A in the blood transfusion donors we
found a mean value which was twice the mean con-
centration reported by Samloff (7). In order to reach
uniformity we corrected our Standard with a factor
of two.
Because of differences in assay characteristics and the
studied populations, any comparison of our study
with those of others has to be interpreted with great
caiition. Nevertheless it is possible to compare trends
in different patient and control groups from this study
with those reported in the literature.
Both pepsinogens showed a leptokurtic and positively
skewed distribution of their serum concentrations.
Square ropt transformation reduced both the lepto-
kurtosis and skewness, and this finding is in agreement
with other studies (11, 12). In nearly all publications
relating to the serum level of pepsinogen A in different
age groups of control sübjects, the same conclusion
was reached äs in this study, i. e. a gradual increase
of pepsinogen A with age, reaching a maximum at
the sixth or seventh decade of life (10, 12-16). We
also found an increase of serum pepsinogen C in older
healthy controls, äs was also seen in other studies (9,
10).
The finding of a higher serum concentration of pep-
sinogen A in males than in females is in agreement
with previous studies (12-17, 19). With respect to
serum pepsinogen C, the picture is more complicated;
some authors described a significantly higher serum
concentration in males than in females (10,18), while,
in agreement with our findings, a more recent study
found no significant difference (9).
In this study, both serum pepsinogens A and C were
increased in duodenal ulcer disease, äs was previously
reported for serum pepsinogen A (10, 15, 16, 20, 21)
and serum pepsinogen C (10, 20). In contrast to other
studies (10, 20), we observed a significant reduction
of the pepsinogen A to pepsinogen C ratio in these
patients. The reason for this discrepancy is not ap-
parent, but may be related to the relatively small
number of patients studied in the preserit report.
In patients having undergone partial gastrectomy we
found a decrease of pepsinogen A in serum, while
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published in the literature for pepsinogen A (2, 7, 17)
and pepsinogen C (2, 7).
In summary, we have developed radioimmunoassays
for both pepsinogen A and C in human serum, and
we have applied these assays to measurements in
healthy blood donors, and in patients with duodenal
ulcer, partial or total gastrectomy and atrophic gas-
tritis.
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serum pepsinogen C showed an increase. This has
also been reported by other authors (3, 15, 22) for
pepsinogen A, while Sipponen et al. (3) reported that
serum pepsinogen C increases in patients having
undergone partial gastrectomy, äs the atrophy of the
mucosa aggravates.
Total gastrectomy caused a strong decrease in the
serum concentrations of both pepsinogens, and their
ratio äs has been reported in other studies (7,10).
Atrophic gastritis caused a decrease of serum pepsi-
nogen A, while serum pepsinogen C was äs high äs
in blood donors. These results fit perfectly with those
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